X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (177) 177
index medicus (176) 176
oncology (164) 164
female (150) 150
middle aged (118) 118
aged (111) 111
adult (101) 101
breast cancer (96) 96
chemotherapy (77) 77
cancer (75) 75
life sciences (75) 75
breast neoplasms - drug therapy (70) 70
male (53) 53
immunology (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
breast neoplasms - pathology (45) 45
aged, 80 and over (44) 44
treatment outcome (42) 42
trastuzumab (32) 32
hematology, oncology and palliative medicine (31) 31
disease-free survival (30) 30
neoplasm metastasis (30) 30
breast neoplasms (28) 28
metastasis (28) 28
paclitaxel (27) 27
france (26) 26
antineoplastic agents - therapeutic use (25) 25
care and treatment (25) 25
metastatic breast cancer (25) 25
survival (25) 25
prognosis (24) 24
therapy (24) 24
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
capecitabine (22) 22
antineoplastic agents (20) 20
bevacizumab (20) 20
breast neoplasms - genetics (20) 20
pharmacology & pharmacy (20) 20
retrospective studies (20) 20
trial (20) 20
analysis (19) 19
antineoplastic combined chemotherapy protocols (19) 19
breast neoplasms - mortality (19) 19
drug administration schedule (19) 19
medicine & public health (19) 19
receptor, erbb-2 - metabolism (19) 19
tumors (19) 19
antibodies, monoclonal, humanized - administration & dosage (18) 18
antineoplastic agents - adverse effects (18) 18
research (18) 18
survival analysis (18) 18
taxoids - administration & dosage (18) 18
neoplasm staging (17) 17
prospective studies (17) 17
antineoplastic agents - administration & dosage (16) 16
chemotherapy, adjuvant (16) 16
cisplatin (16) 16
follow-up (16) 16
france - epidemiology (16) 16
women (16) 16
adjuvant chemotherapy (15) 15
carcinoma (15) 15
clinical trials (15) 15
combination (15) 15
efficacy (15) 15
obstetrics & gynecology (15) 15
breast neoplasms - metabolism (14) 14
docetaxel (14) 14
fluorouracil (14) 14
taxane (14) 14
cancer therapies (13) 13
risk assessment (13) 13
risk factors (13) 13
studies (13) 13
time factors (13) 13
antimitotic agents (12) 12
breast neoplasms - diagnosis (12) 12
colorectal cancer (12) 12
deoxycytidine - analogs & derivatives (12) 12
kaplan-meier estimate (12) 12
mammography (12) 12
neoplasm recurrence, local - drug therapy (12) 12
open-label (12) 12
patients (12) 12
safety (12) 12
young adult (12) 12
animals (11) 11
antibodies, monoclonal, humanized (11) 11
antineoplastic agents - pharmacokinetics (11) 11
breast neoplasms - chemistry (11) 11
drug therapy (11) 11
fluorouracil - administration & dosage (11) 11
internal medicine (11) 11
receptor, erbb-2 - genetics (11) 11
taxoids (11) 11
cisplatin - administration & dosage (10) 10
doxorubicin (10) 10
epidermal growth factor (10) 10
fluorouracil - analogs & derivatives (10) 10
health aspects (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC cancer, ISSN 1471-2407, 06/2019, Volume 19, Issue 1, pp. 620 - 620
Following publication of the original article [1], the authors reported the following errors in the article. 
Journal Article
Intensive care medicine experimental, ISSN 2197-425X, 05/2019, Volume 7, Issue 1, pp. 28 - 13
Septic shock patients exhibit an increased incidence of viral reactivation. Precise timing of such reactivation-as an early marker of immune suppression, or as... 
Viruses | Sepsis | Automation | Mortality | Viral infections | EBV | Immunosuppression | Biomarker | Herpes viruses
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2019, Volume 120, pp. 1 - 9
We assessed long-term cardiac safety and efficacy in patients with human epidermal growth factor receptor 2–positive early breast cancer treated with a... 
Long-term extension study | SB3 | Trastuzumab | Biosimilar | Antibody-dependent cell-mediated cytotoxicity | Index Medicus
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2019, Volume 20, Issue 8, pp. 1043 - 1044
Journal Article
Cancer, ISSN 0008-543X, 07/2019
In the phase 3 MARIANNE trial, trastuzumab emtansine (T-DM1) with or without pertuzumab showed noninferior progression-free survival and better tolerability... 
Index Medicus | Abridged Index Medicus
Journal Article
by Pivot, Xavier and Romieu, Gilles and Debled, Marc and Pierga, Jean-Yves and Kerbrat, Pierre and Bachelot, Thomas and Lortholary, Alain and Espié, Marc and Fumoleau, Pierre and Serin, Daniel and Jacquin, Jean-Philippe and Jouannaud, Christelle and Rios, Maria and Abadie-Lacourtoisie, Sophie and Venat-Bouvet, Laurence and Cany, Laurent and Catala, Stéphanie and Khayat, David and Gambotti, Laetitia and Pauporté, Iris and Faure-Mercier, Celine and Paget-Bailly, Sophie and Henriques, Julie and Grouin, Jean Marie and Piprot, C and Cals, L and Chaigneau, L and Demarchi, F and N'Guyen, T and Stein, U and Villanueva, C and Bréau, JL and Chouahnia, AK and Saintigny, P and Boué, F and deSaint-Hilaire, P and Guimont, I and Grossat, N and Valenza, B and Lévy, E and Médioni, J and Delbaldo, C and Grenier, J and Pouessel, D and Lavau-Denès, S and Falandry, C and Fournel-Fédérico, C and Freyer, G and Tartas, S and Trillet-Lenoir, V and Bons, F and Auclerc, G and Chièze, S and Raban, N and Tournigand, C and Trager-Maury, S and Bousquet, G and Cuvier, C and Giacchetti, S and Hocini, A and LeMaignan, C and Misset, JL and Avenin, D and Beerblock, C and Gligorov, J and Rivera, P and Roché, H and Bougnoux, P and Hajjaji, N and Capitain, O and Delva, R and Maillart, P and Soulié, P and Bonnefoi, H and Durand, M and Madranges, N and Mauriac, L and Chollet, P and Dillies, AF and Durando, X and Ferrière, JP and Mouret-Reynier, C and Nabholtz, JM and Van Praagh, I and Cottu, P and Diéras, V and Durieux, A and Galotte, M and Girre, V and Henry, S and Iurisci, I and Jouve, M and Laurence, V and Mignot, L and Piperno-Neumann, S and Tresca, P and Coudert, B and Ferrant, E and Mayer, F and Vanneuville, AC and ... and PHARE Trial Investigators and PHARE trial investigators
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15014 - e15014
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12505 - e12505
Journal Article
JAMA ONCOLOGY, ISSN 2374-2437, 05/2019, Volume 5, Issue 5, pp. e190339 - e190339
IMPORTANCE Confirmation of long-term comparability between subcutaneous and intravenous trastuzumab is essential. OBJECTIVE To evaluate efficacy and safety of... 
ONCOLOGY | Index Medicus | Brief Report | Online First | Online Only | Research
Journal Article
The Breast, ISSN 0960-9776, 04/2019, Volume 44, p. 39
Adjuvant chemotherapy shows clear benefits in HER2-positive and triple-negative breast cancer (BC). Its benefits are less universal in BCs expressing hormone... 
Oncology, Experimental | Adjuvant treatment | Breast cancer | Postmenopausal women | Research | Cancer
Journal Article
by Nik-Zainal, Serena and Davies, Helen and Staaf, Johan and Ramakrishna, Manasa and Glodzik, Dominik and Zou, Xueqing and Martincorena, Inigo and Alexandrov, Ludmil B and Martin, Sancha and Wedge, David C and Van Loo, Peter and Ju, Young Seok and Smid, Marcel and Brinkman, Arie B and Morganella, Sandro and Aure, Miriam R and Lingjærde, Ole Christian and Langerød, Anita and Ringnér, Markus and Ahn, Sung-Min and Boyault, Sandrine and Brock, Jane E and Broeks, Annegien and Butler, Adam and Desmedt, Christine and Dirix, Luc and Dronov, Serge and Fatima, Aquila and Foekens, John A and Gerstung, Moritz and Hooijer, Gerrit K J and Jang, Se Jin and Jones, David R and Kim, Hyung-Yong and King, Tari A and Krishnamurthy, Savitri and Lee, Hee Jin and Lee, Jeong-Yeon and Li, Yilong and McLaren, Stuart and Menzies, Andrew and Mustonen, Ville and O'Meara, Sarah and Pauporté, Iris and Pivot, Xavier and Purdie, Colin A and Raine, Keiran and Ramakrishnan, Kamna and Rodríguez-González, F Germán and Romieu, Gilles and Sieuwerts, Anieta M and Simpson, Peter T and Shepherd, Rebecca and Stebbings, Lucy and Stefansson, Olafur A and Teague, Jon and Tommasi, Stefania and Treilleux, Isabelle and Van den Eynden, Gert G and Vermeulen, Peter and Vincent-Salomon, Anne and Yates, Lucy and Caldas, Carlos and Van't Veer, Laura and Tutt, Andrew and Knappskog, Stian and Tan, Benita Kiat Tee and Jonkers, Jos and Borg, Åke and Ueno, Naoto T and Sotiriou, Christos and Viari, Alain and Futreal, P Andrew and Campbell, Peter J and Span, Paul N and Van Laere, Steven and Lakhani, Sunil R and Eyfjord, Jorunn E and Thompson, Alastair M and Birney, Ewan and Stunnenberg, Hendrik G and van de Vijver, Marc J and Martens, John W M and Børresen-Dale, Anne-Lise and Richardson, Andrea L and Kong, Gu and Thomas, Gilles and Stratton, Michael R
Nature, ISSN 0028-0836, 01/2019, Volume 566, Issue 7742, pp. E1 - E1
In the Methods section of this Article, 'greater than' should have been 'less than' in the sentence 'Putative regions of clustered rearrangements were... 
Medical colleges | Breast cancer | Genetic aspects | Genomes | Genomics
Journal Article
Future oncology (London, England), ISSN 1479-6694, 11/2018, Volume 14, Issue 27, pp. 2795 - 2803
The development of a biosimilar requires large extensive preclinical and clinical comparability exercises to demonstrate equivalence to the reference medical... 
trastuzumab | breast cancer | biosimilar | SAFETY | FOLLOW-UP | NEOADJUVANT THERAPY | OPEN-LABEL | RANDOMIZED PHASE-I | HER2-POSITIVE BREAST-CANCER | CHEMOTHERAPY | ADJUVANT TRASTUZUMAB | PHARMACOKINETICS | ONCOLOGY | CONTROLLED SUPERIORITY TRIAL
Journal Article
Journal Article